Mortality and Recurrence Risk in Relation to the Use of Lipid-Lowering Drugs in a Prospective Breast Cancer Patient Cohort

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Nickels, Stefan ^a   Vrieling, Alina ^a,b   Seibold, Petra ^a   Heinz, Judith ^c   Obi, Nadia ^c   Flesch Janys, Dieter ^c   Chang Claude, Jenny ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; ECHOMAMMOGRAPHY; FEMALE; FOLLOW UP; GERMANY; HORMONAL THERAPY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; METASTASIS; MORTALITY; POSTMENOPAUSE; RECURRENCE RISK; RISK REDUCTION; SELF REPORT; SMOKING;

AGE FACTORS; AGED; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GERMANY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, STEROID; RISK ASSESSMENT;

EID: 84884564996     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075088     Document Type: Article

References (21)

1. Schwabe U, Paffrath D (2010) Arzneiverordnungs-Report 2010: Springer-Verlag, Berlin/Heidelberg/New York.
2. Katz MS, (2005) Therapy insight: Potential of statins for cancer chemoprevention and therapy. Nat Clin Pract Oncol 2: 82-89.
3. Jakobisiak M, Golab J, (2003) Potential antitumor effects of statins (Review). Int J Oncol 23: 1055-1069.
4. Vaklavas C, Chatzizisis YS, Tsimberidou AM, (2011) Common cardiovascular medications in cancer therapeutics. Pharmacology & Therapeutics 130: 177-190.
5. Gopalan A, Yu W, Sanders BG, Kline K, (2013) Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway. Cancer Lett 329: 9-16.
6. Undela K, Srikanth V, Bansal D, (2012) Statin use and risk of breast cancer: a meta-analysis of observational studies. Breast Cancer Res Treat 135: 261-269.
7. Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, et al. (2011) Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study. Journal of the National Cancer Institute 103: 1461-1468.
8. Chae YK, Valsecchi ME, Kim J, Bianchi AL, Khemasuwan D, et al. (2011) Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins. Cancer Investigation 29: 585-593.
9. Kwan ML, Habel LA, Flick ED, Quesenberry CP, Caan B, (2008) Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat 109: 573-579.
10. Nielsen SF, Nordestgaard BG, Bojesen SE, (2012) Statin use and reduced cancer-related mortality. N Engl J Med 367: 1792-1802.
11. Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, et al. (2008) Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. International Journal of Cancer 123: 933-941.
12. Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. New York: Springer. xiii, 350 p. p.
13. Lin DY, Wei LJ, Ying Z, (1993) Checking the Cox Model with Cumulative Sums of Martingale-Based Residuals. Biometrika 80: 557-572.
14. Holmes MD, Chen WY, (2012) Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality. Breast Cancer Res 14: 216.
15. Calip GS, Boudreau DM, Loggers ET (2013) Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment. Breast Cancer Res Treat.
16. Ozdemir BH, Akcali Z, Haberal M, (2004) Hypercholesterolemia impairs angiogenesis in patients with breast carcinoma and, therefore, lowers the risk of metastases. Am J Clin Pathol 122: 696-703.
17. Protani M, Coory M, Martin JH, (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123: 627-635.
18. Ewertz M, Jensen MB, Gunnarsdottir KA, Hojris I, Jakobsen EH, et al. (2011) Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 29: 25-31.
19. Bosco JL, Silliman RA, Thwin SS, Geiger AM, Buist DS, et al. (2010) A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol 63: 64-74.
20. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, et al. (2002) Long-term persistence in use of statin therapy in elderly patients. JAMA 288: 455-461.
21. Latry P, Molimard M, Dedieu B, Couffinhal T, Begaud B, et al. (2011) Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study. BMC Cardiovasc Disord 11: 46.